Photo from Kevin Punie/X
May 19, 2024, 10:25
Kevin Punie: Carmen Criscit provides excellent guidance in decision making between Olaparib and Abemaciclib
Kevin Punie, Medical Oncologist at GZA Hospitals Sint-Augustinus, Wilrijk, Antwerp, Belgium shared a post on X:
“Carmen Criscit provides excellent guidance in decision making between olaparib and abemaciclib in patients with early-stage high-risk HR+/HER2- breast cancer with overlapping indications.”
Source: Kevin Punie/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 12:14
Nov 14, 2024, 12:09
Nov 14, 2024, 11:56
Nov 14, 2024, 11:49
Nov 14, 2024, 11:46
Nov 14, 2024, 11:38
Nov 14, 2024, 11:30
Nov 14, 2024, 09:31
Nov 14, 2024, 09:26